| Outcome Measures: |
Primary: Time in range, Difference in time spent with glucose values in the range 3.9-10.0 mmol/l between Fiasp and Iasp treatment assessed by continuous glucose monitoring, Last two weeks of the 16-week interventions | Secondary: Mean glucose, Difference in mean glucose between Fiasp and Iasp treatment assessed by continuous glucose monitoring, Last two weeks of the 16-week interventions|Coefficient of variation, Difference in coefficient of variation between Fiasp and Iasp treatment assessed by continuous glucose monitoring, Last two weeks of the 16-week interventions|Time below range level 1, Difference in time spent with glucose values below 3.9 mmol/l between Fiasp and Iasp treatment assessed by continuous glucose monitoring, Last two weeks of the 16-week interventions|Time below range level 2, Difference in time spent with glucose values below 3.0 mmol/l between Fiasp and Iasp treatment assessed by continuous glucose monitoring, Last two weeks of the 16-week interventions|Time above range level 1, Difference in time spent with glucose values above 10.0 mmol/l between Fiasp and Iasp treatment assessed by continuous glucose monitoring, Last two weeks of the 16-week interventions|Time above range level 2, Difference in time spent with glucose values above 13.9 mmol/l between Fiasp and Iasp treatment assessed by continuous glucose monitoring, Last two weeks of the 16-week interventions|Fructosamine, Difference in change in fructosamine between Fiasp and Iasp treatment, 16 weeks|Total daily insulin dose, Difference between Fiasp and Iasp treatment in total daily insulin dose, Last two weeks of the 16-week interventions|Total daily basal insulin dose, Difference between Fiasp and Iasp treatment in total daily basal insulin dose, Last two weeks of the 16-week interventions|Total daily bolus insulin dose, Difference between Fiasp and Iasp treatment in total daily bolus insulin dose, Last two weeks of the 16-week interventions|Severe hypoglycemia, Difference between Fiasp and Iasp treatment in number of severe hypoglycemia events, 16 weeks|Ketoacidosis, Difference between Fiasp and Iasp treatment in number of ketoacidosis events, 16 weeks
|
